Nicht aus der Schweiz? Besuchen Sie lehmanns.de
U.S. Patent Opinions and Evaluations - David L. Fox

U.S. Patent Opinions and Evaluations

(Autor)

Buch | Softcover
1072 Seiten
2009
Oxford University Press Inc (Verlag)
978-0-19-536727-0 (ISBN)
CHF 339,95 inkl. MwSt
zur Neuauflage
  • Titel erscheint in neuer Auflage
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage
This book provides expert, up-to-date, practical advice and guidance on the four principle issues of patent evaluations and opinions, including: (1) claim construction and claim scope; (2) infringement; (3) validity; and (4) enforceability.
The book teaches how to apply these four principles to the many uses of patent opinions, including: - Evaluating and Opining on Third-Party Patents for: --- Willful Infringement Risk Analyses --- Invalidity and Noninfringement Investigations and Opinions for Avoidance of Willful Infringement ---Infringement Risk and Patent Portfolio Analyses and Reporting for SEC Compliance, Including Sarbanes-Oxley Reporting --- Clearance (Freedom to Operate) Investigations and Opinions for New Products and Process --- Design-Around Investigations and Determinations --- Pre-Purchase and Pre-License Investigations of Patent Scope, Validity, and Enforceability --- Pre-Filing Investigations for Ex Parte Reexamination and Other Post-Grant Challenges L - Evaluating and Opining on One's Own Patent Rights for: --- Pre-Filing Infringement, Validity, and Enforceability Investigations for Rule 11 Compliance --- Evaluation of Patent Portfolio Strength and Scope --- Pre-Filing Investigations for Reexamination and Reissue Filings --- Pre-Sale and Pre-Licensing Investigations of Patent Scope, Validity, and Enforceability ---Protecting and Maximizing Patent Rights in Bankruptcy

David Fox is Of Counsel, Osha Liang LLP. In addition to a J.D. from Loyola University, he has a PhD in microbiology from Columbia University. His experience extends from scientific publishing and research in the areas of molecular biology, cancer biology, immunology, microbiology, biotechnology, and agriculture to practicing intellectual property law, including opinions, licensing, litigation and prosecution in all areas, including biotechnology and chemistry.

PREFACE HOW TO BEST USE THIS BOOK; CHAPTER 1 OVERVIEW AND USES OF PATENT NONINFRINGEMENT AND INVALIDITY; OPINIONS; I. PURPOSES AND USES OF PATENT NONINFRINGEMENT AND INVALIDITY OPINIONS; II. NONINFRINGEMENT OPINIONS; III. INVALIDITY OPINIONS; CHAPTER 2 COMPETENCY OF OPINIONS; I. REQUIREMENT FOR COMPETENT OPINION; II. CLAIM CONSTRUCTION REQUIRED; III. RELIANCE OF CITED, UP-TO-DATE, PROPERLY INTERPRETED LAW; IV. TIMING FOR OPINIONS; V. NONINFRINGEMENT OPINIONS; VI. INVALIDITY OPINIONS; VII. FINAL OPINION SHOULD BY IN WRITING; VIII. LEVEL OF CERTAINTY; IV. PRACTICE TIPS; CHAPTER 3 TIMING, NECESSITY OF, AND RELIANCE ON OPINIONS; I. KNORR-BREMSE CASE; II. READ FACTORS REMAIN; III. BEST TO OBTAIN OPINION UPON LEARNING OF POTENTIALLY INFRINGED PATENT; IV. WAIVER; V. PRACTICE TIPS; CHAPTER 4 WAIVER OF ATTORNEY-CLIENT PRIVILEGE AND WORK-PRODUCT IMMUNITY; I. PRODUCTION OF OPINION; II. WAIVER OF ATTORNEY-CLIENT PRIVILEGE; III. OTHER WAIVERS; IV. PRACTICE TIPS; CHAPTER 5 CLAIM CONSTRUCTION; I. COMPETENT OPINION MUST CONSTRUE CLAIMS; II. EVIDENCE FOR CLAIM CONSTRUCTION; III. CLAIM CONSTRUCTION; VII. PRACTICE TIPS; CHAPTER 6 ESTABLISHING BASIS FOR NONINFRINGEMENT OPINIONS; I. COMPETENT OPINION MUST CONSTRUE CLAIMS; II. BURDEN OF PROOF FOR NONINFRINGEMENT IS PREPONDERANCE OF THE EVIDENCE (CENTRICUT); III. CAREFULLY AND ACCURATELY DESCRIBE CLIENT'S TECHNOLOGY; IV. ADVISE CLIENT IN WRITING, IN FINAL OPINION, THAT NONINFRINGEMENT ANALYSIS AND OPINION ARE BASED SOLELY ON CLIENT'S PRODUCT AND/OR PROCESS AS DESCRIBED IN OPINION, AND THAT ANY CHANGES TO PRODUCT AND/OR PROCESS MUST BE EVALUATED ANEW FOR NONINFRINGEMENT; IV. A. BEGIN WITH ANALYSIS OF LITERAL INFRINGEMENT; V. PRACTICE TIPS; CHAPTER 7 LITERAL INFRINGEMENT; I. LITERAL INFRINGEMENT (35 U.S.C. 271(A)); II. SPECIAL RULES; III. DOCTRINE OF EQUIVALENTS MUST BE ADDRESSED IF NO LITERAL INFRINGEMENT; IV. PRACTICE TIPS; CHAPTER 8 DOCTRINE OF EQUIVALENTS; I. INFRINGEMENT UNDER THE DOCTRINE OF EQUIVALENTS; II. DEFINING EQUIVALENTS; III. SPECIAL CLAIM CONSTRUCTION RULES FOR EQUIVALENTS; IV. SPECIAL RULES; V. PRACTICE TIPS; CHAPTER 9 NON-DIRECT INFRINGEMENT, EXPERIMENTAL USE, AND IMPLIED LICENSE; I. DIRECT INFRINGEMENT (35 U.S.C. 271(A)); II. NON-DIRECT INFRINGEMENT; III. INDUCEMENT; IV. CONTRIBUTORY INFRINGEMENT; V. FOREIGN ACTIVITY; VI. IMPORTATION OF PRODUCT MADE BY METHOD CLAIM; VII. EXPERIMENTAL USE EXEMPTION (35 U.S.C. 271(E)(1)); VIII. IMPLIED LICENSE; IX. PRACTICE TIPS; CHAPTER 10 ESTABLISHING THE BASIS FOR INVALIDITY OPINIONS; I. COMPETENT OPINION MUST CONSTRUE CLAIMS; II. BURDEN OF PROOF FOR PATENT INVALIDITY IS CLEAR AND CONVINCING EVIDENCE (TYPERIGHT KEYBOARD); III. MULTIPLE AVENUES TO PROVE INVALIDITY; IV. NO NEED TO EVALUATE CLIENT'S TECHNOLOGY; V. PRACTICE TIPS; CHAPTER 11 ANTICIPATION BY PRINTED PUBLICATION; I. THE INVENTION WAS DESCRIBED IN A PRINTED PUBLICATION MORE THAN ONE YEAR BEFORE THE PRIORITY DATE (35 U.S.C. 102(B)); II. QUALIFYING THE PRIOR ART; III. SINGLE SOURCE OF PRIOR ART MUST CONTAIN ALL OF THE LIMITATIONS OF THE CLAIM, EXPRESSLY OR INHERENTLY (METABOLITE LABORATORIES); IV. WEIGHT OF PRIOR ART; V. PARENT APPLICATION AS PRIOR ART AGAINST CONTINUATION-IN-PART PATENT; IV. PRACTICE TIPS; CHAPTER 12 OTHER FORMS OF ANTICIPATION; I. ON SALE BAR, 35 U.S.C. 102(B); II. PUBLIC USE, 35 U.S.C. 102(B); III. KNOWN OR USED BY OTHERS IN THE U.S., 35 U.S.C. 102(A); IV. PATENTED OR DESCRIBED IN A PRINTED PUBLICATION, 35 U.S.C. 102(A); V. DESCRIBED IN A U.S. PATENT APPLICATION PUBLISHED BY ANOTHER FILED IN THE U.S. BEFORE THE INVENTION DATE, 35 U.S.C. 102(E)(1); VI. DESCRIBED IN A U.S. PATENT BY ANOTHER FILED IN THE U.S. BEFORE THE INVENTION DATE, 35 U.S.C. 102(E)(2); VII. DERIVATION, 35 U.S.C. 102(F); VIII. PRIOR INVENTION, 35 U.S.C. 102(G); IX. PRACTICE TIPS; CHAPTER 13 OBVIOUSNESS; I. OVERVIEW; II. ESTABLISHING A PRIMA FACIE CASE OF OBVIOUSNESS; III. EVIDENCE FOR REBUTTAL OF PRIMA FACIE CASE OF OBVIOUSNESS: GRAHAM SECONDARY CONSIDERATIONS; IV. SECONDARY FACTORS CANNOT REBUT A CLEAR CASE OF OBVIOUSNESS (GRAHAM); V. SUMMARY OF NONOBVIOUSNESS OPINION; VI. PRACTICE TIPS; CHAPTER 14 OTHER FORMS OF INVALIDITY, UNENFORCEABILITY; I. WRITTEN DESCRIPTION, 35 U.S.C. 112, FIRST PARAGRAPH; II. ENABLEMENT, 35 U.S.C. 112, FIRST PARAGRAPH; III. BEST MODE, 35 U.S.C. 112, FIRST PARAGRAPH; IV. INDEFINITENESS, 35 U.S.C. 112, SECOND PARAGRAPH; V. UTILITY, 35 U.S.C. 101; VI. INEQUITABLE CONDUCT, UNENFORCEABILITY; VII. PRACTICE TIPS; APPENDIX A SAMPLE OUTLINE OF NONINFRINGEMENT OPINION; APPENDIX B SAMPLE OUTLINE OF INVALIDITY OPINION; APPENDIX C SUBJECT MATTER INDEX

Erscheint lt. Verlag 12.11.2009
Verlagsort New York
Sprache englisch
Maße 156 x 234 mm
Gewicht 1488 g
Themenwelt Recht / Steuern EU / Internationales Recht
Recht / Steuern Wirtschaftsrecht Urheberrecht
ISBN-10 0-19-536727-8 / 0195367278
ISBN-13 978-0-19-536727-0 / 9780195367270
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
und verwandte Schutzrechte

von Heinrich Hubmann; Manfred Rehbinder; Alexander Peukert

Buch | Softcover (2023)
C.H.Beck (Verlag)
CHF 48,85
Kommentar

von Herbert Grziwotz; Jörn Heinemann

Buch | Hardcover (2024)
Carl Heymanns (Verlag)
CHF 179,95
Urheberrechtsgesetz, Verlagsgesetz, Recht der urheberrechtlichen …

von Hans-Peter Hillig

Buch | Softcover (2023)
dtv Verlagsgesellschaft
CHF 24,95